James Patrick Kelly
EVP, CFO and Treasurer at Novavax Inc (NVAX) since August 2021
James Patrick Kelly has filed 20 insider reports with the SEC since February 2021, as EVP and CFO and Treasurer at Novavax Inc (NVAX) and officer at Supernus Pharmaceuticals, Inc. (SUPN). The latest filing, on March 9, 2026, reports shares withheld for taxes or exercise price and exercise or conversion of a derivative at Novavax Inc (NVAX).
- Filings
- 20
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where James Patrick Kelly is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| EVP, CFO and Treasurersince August 2021 | 130,599 | $7.72 | Mar 9, 2026 | ||||
| Officer | $28.35 | Feb 23, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 7, 2026NVAXEVP, CFO and Treasurer Kelly James Patrick converted options into 12,223 shares and covered exercise/tax liability with 5,904 shares, increasing direct ownership by 5% to 130,599 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 2, 2026NVAXAmendment: SEC Form 4 filed by EVP, CFO and Treasurer Kelly James PatrickForm 4Grant or award
- Mar 3, 2026NVAXEVP, CFO and Treasurer Kelly James Patrick converted options into 43,167 shares and covered exercise/tax liability with 20,850 shares, increasing direct ownership by 22% to 124,280 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 2, 2026NVAXEVP, CFO and Treasurer Kelly James Patrick converted options into 58,666 shares and covered exercise/tax liability with 28,366 shares, increasing direct ownership by 42% to 101,963 unitsForm 4Grant or awardSale back to the companyShares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 7, 2025NVAXEVP, CFO and Treasurer Kelly James Patrick converted options into 12,223 shares and covered exercise/tax liability with 5,904 shares, increasing direct ownership by 10% to 69,251 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 3, 2025NVAXSEC Form 4 filed by EVP, CFO and Treasurer Kelly James PatrickForm 4Grant or award
- Mar 1, 2025NVAXEVP, CFO and Treasurer Kelly James Patrick converted options into 58,667 shares and covered exercise/tax liability with 28,337 shares, increasing direct ownership by 93% to 62,932 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Dec 31, 2024NVAXEVP, CFO and Treasurer Kelly James Patrick covered exercise/tax liability with 16,906 shares and converted options into 35,000 shares, increasing direct ownership by 125% to 32,602 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Aug 16, 2024NVAXEVP, CFO and Treasurer Kelly James Patrick exercised 2,367 shares at a strike of $12.96 and covered exercise/tax liability with 1,223 shares, increasing direct ownership by 9% to 14,429 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 1, 2024NVAXSEC Form 4 filed by Kelly James PatrickForm 4Grant or award
- Mar 10, 2024NVAXKelly James Patrick converted options into 4,608 shares and covered exercise/tax liability with 2,226 shares, increasing direct ownership by 22% to 13,285 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 7, 2024NVAXKelly James Patrick converted options into 12,224 shares and covered exercise/tax liability with 5,905 shares, increasing direct ownership by 138% to 10,903 unitsForm 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- Aug 16, 2023NVAXSEC Form 4: Kelly James Patrick covered exercise/tax liability with 1,143 shares and converted options into 2,366 shares, increasing direct ownership by 36% to 4,584 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 10, 2023NVAXSEC Form 4: Kelly James Patrick exercised 4,609 shares at a strike of $6.52 and covered exercise/tax liability with 2,471 shares, increasing direct ownership by 175% to 3,361 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 7, 2023NVAXSEC Form 4 filed by Kelly James PatrickForm 4Grant or award
- Aug 16, 2022NVAXSEC Form 4: Kelly James Patrick converted options into 2,367 shares and covered exercise/tax liability with 1,144 sharesForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 10, 2022NVAXSEC Form 4 filed by Kelly James PatrickForm 4Grant or award
- Aug 16, 2021NVAXSEC Form 4 filed by Kelly James PatrickForm 4Grant or award
- Aug 16, 2021NVAXSEC Form 3 filed by Kelly James PatrickForm 3New insider
- Feb 19, 2021SUPNSEC Form 4 filed by Patrick James KellyForm 4Grant or award
Compare James Patrick Kelly with
- James Patrick Kelly vs Georges Gemayel1 shared
- James Patrick Kelly vs William Todd Horich1 shared
- James Patrick Kelly vs Jack A. Khattar1 shared
- James Patrick Kelly vs Timothy C Dec1 shared
- James Patrick Kelly vs Carrolee Barlow1 shared
- James Patrick Kelly vs Padmanabh P. Bhatt1 shared
Other insiders at the same companies
- Georges GemayelSUPN
- William Todd HorichSUPN
- Jack A. KhattarSUPN
- Timothy C DecSUPN
- Carrolee BarlowSUPN
- Padmanabh P. BhattSUPN
- Jonathan RubinSUPN
- Frank MottolaSUPN
- Charles W Newhall IIISUPN
- Frederick M. HudsonSUPN
- Bethany SensenigSUPN
- Richard J RodgersNVAX
- Rachel K. KingNVAX
- Richard DouglasNVAX
- Margaret G McglynnNVAX
- David M MottNVAX
Questions about James Patrick Kelly
- What is James Patrick Kelly's role at Novavax Inc?
- James Patrick Kelly reports to the SEC as EVP and CFO and Treasurer at Novavax Inc (NVAX), according to the latest filing on March 9, 2026. James Patrick Kelly has also filed as officer at Supernus Pharmaceuticals, Inc. (SUPN).
- How many shares does James Patrick Kelly own?
- After the latest filing that states it, James Patrick Kelly directly owned 130,599 shares of Novavax Inc (NVAX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has James Patrick Kelly bought or sold stock recently?
- No open-market purchases or sales by James Patrick Kelly are on file. The filings report shares withheld for taxes or exercise price, exercise or conversion of a derivative, grant or award and sale back to the company.
- How do I get alerts when James Patrick Kelly files?
- Follow James Patrick Kelly on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by James Patrick Kelly (SEC CIK 0001506314). Totals count each trade once, skipping amendments whose original is on file, from Feb 23, 2021 on. View on SEC EDGAR · Get this as JSON